Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver
Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T.
Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
1985
ISSN/ISBN: 0389-4118 PMID: 4062669 Document Number: 251591
Document emailed within 1 workday
Related Documents
Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Baldi, E.; Burra, P.; Plebani, M.; Salvagnini, M. 1993: Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease Italian Journal of Gastroenterology 25(8): 429-432
Abenavoli, L.; Luigiano, C.; Guzzi, P.H.; Milic, N.; Morace, C.; Stelitano, L.; Consolo, P.; Miraglia, S.; Fagoonee, S.; Virgilio, C.; Luzza, F.; De Lorenzo, A.; Pellicano, R. 2014: Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease Panminerva Medica 56(2): 189-193
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Abenavoli, L.; Milic, N.; Luigiano, C. 2014: Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease Minerva Medica 105(2): 175
Schnabel, R.; Jaszovszky, S.; Bokor, M.; Garam, T. 1991: Serum aminoterminal type III procollagen peptide level and killer cell activity in patients with alcoholic liver diseases Orvosi Hetilap 132(27): 1479-1483
Madan, K.; Dhingra, A. 2012: Mortality and non-alcoholic fatty liver disease: type of study cohort matters! National Medical Journal of India 25(1): 28-30
Liu, Y.; Hong, T. 2015: The pathogenesis and management of non-alcoholic fatty liver disease coexisted with type 2 diabetes Zhonghua Yi Xue Za Zhi 95(44): 3565-3567
Darmawan, G.; Hamijoyo, L.; Hasan, I. 2017: Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis Acta Medica Indonesiana 49(2): 136-147
Tahan, V.; Canbakan, B.; Balci, H.; Dane, F.; Akin, H.; Can, G.; Hatemi, I.; Olgac, V.; Sonsuz, A.; Ozbay, G.; Yurdakul, I.; Senturk, H. 2008: Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk Hepato-Gastroenterology 55(85): 1433-1438
Akhmedov, V.A.; P'iannikov, V.V.; Keruchenko, A.L. 2011: Comparison of the immune response in patients with alcoholic liver disease and non-alcoholic steatohepatitis Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 22-25
Shukla, V.; Fatima, J.; Chaudhary, S.; Ali, M.; Mishra, I. 2017: A Study of Endothelial Dysfunction in Patients of Non-Alcoholic Fatty Liver Disease Journal of the Association of Physicians of India 65(9): 18-22
Majumdar, S.K.; Shaw, G.K.; Aps, E.J.; Thomson, A.D. 1981: Alcoholic liver disease among alcoholic patients in a psychiatric hospital Practitioner 225(1362): 1833-1835
Testino, G.; Ferro, C. 2007: Type-1 hepatorenal syndrome in patients with alcoholic end stage liver disease listed for liver transplantation: role of transjugular intrahepatic portosystemic stent shunt Panminerva Medica 49(1): 43-45
Bannister, P.; Oakes, J.; Sheridan, P.; Losowsky, M.S. 1987: Sex hormone changes in chronic liver disease: a matched study of alcoholic versus non-alcoholic liver disease Quarterly Journal of Medicine 63(240): 305-313
Livanov, G.A.; Shikalova, I.A.; Lodyagin, A.N.; Glushkov, S.; Batotsyrenov, B.V.; Loladze, A.T.; Kovalenko, A.L. 2016: [Features of Pharmacological Correction of Alcoholic Fatty Liver Disease in Patients with Acute Ethanol Intoxication Eksperimental'naia i Klinicheskaia Gastroenterologiia 2016(5): 45-50
Swiatkowska-Stodulska, R.; Bakowska, A. 2004: Serum interleukin-6 concentrations in patients with alcoholic liver disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(99): 255-259
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Wu, S.-L.; Lu, C.-L.; Chun, B.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha Hepato-Gastroenterology 54(79): 2099-2102